Please login to the form below

What next for the treatment of Psoriasis in Europe?

Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.

Over the last decade, systemic biologic therapies for Psoriasis (PsO) have become widespread and the development of biological therapies has revolutionized the treatment of the disease. A chronic autoimmune disease, psoriasis has an estimated prevalence of 2.5% in Europe, representing approximately 15 million people, with 20–25% of these suffering from severe disease...

Read the article: https://www.researchpartnership.com/news/2017/03/article-what-next-for-the-treatment-of-psoriasis-in...


11th April 2017

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Video
Virtual Conference Live
Research Partnership
Report
Digital Health Tools - Physician Trends
Research Partnership
Live webinar:
Oncology landscape: How innovative market research methods can navigate you to success
Research Partnership
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Research Partnership
Research Partnership’s MedTech Division appoints two Directors
Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.
Research Partnership
Webcast: Influencing HCP behaviours – Is now the perfect opportunity?
Putting behavioural science at the forefront of market research
Research Partnership